[
  {
    "ts": "2026-02-25T12:57:47+00:00",
    "headline": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More",
    "summary": "Pre-Market Stock Futures: Futures are trading higher this morning, but what a difference a day makes after a “Meltdown Monday.” Stocks rallied on Tuesday, and all major indices closed higher. While not recouping all of the losses from Monday, a strong bounce-back was a welcome sight for investors. A combination of a rebound in technology ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More",
    "url": "https://247wallst.com/investing/2026/02/25/here-are-wednesdays-top-wall-street-analyst-research-calls-abbvie-angel-studios-first-solar-ibm-kroger-molson-coors-oracle-workday-and-more/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "4169d733-42be-3151-835b-ba5bd346912c",
      "content": {
        "id": "4169d733-42be-3151-835b-ba5bd346912c",
        "contentType": "STORY",
        "title": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More",
        "description": "",
        "summary": "Pre-Market Stock Futures: Futures are trading higher this morning, but what a difference a day makes after a “Meltdown Monday.” Stocks rallied on Tuesday, and all major indices closed higher. While not recouping all of the losses from Monday, a strong bounce-back was a welcome sight for investors. A combination of a rebound in technology ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More",
        "pubDate": "2026-02-25T12:57:47Z",
        "displayTime": "2026-02-25T12:57:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/8338f370f249766d037be2988fc68cf3",
          "originalWidth": 1366,
          "originalHeight": 768,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8oHqLvL4LSIh_k84TF28VQ--~B/aD03Njg7dz0xMzY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/8338f370f249766d037be2988fc68cf3.cf.webp",
              "width": 1366,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M2B5MfoEY0V7wX_NrqStUQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/8338f370f249766d037be2988fc68cf3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2026/02/25/here-are-wednesdays-top-wall-street-analyst-research-calls-abbvie-angel-studios-first-solar-ibm-kroger-molson-coors-oracle-workday-and-more/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wednesday-top-wall-street-analyst-125747007.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "TREX"
            },
            {
              "symbol": "KNSL"
            },
            {
              "symbol": "ENPH"
            },
            {
              "symbol": "OVV"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "LYV"
            },
            {
              "symbol": "PFG"
            },
            {
              "symbol": "ANGX"
            },
            {
              "symbol": "FSLR"
            },
            {
              "symbol": "IBM"
            },
            {
              "symbol": "KR"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "WDAY"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-25T14:57:20+00:00",
    "headline": "Large cap pharma defensive AI winner, says RBC as it backs Lilly & AbbVie",
    "summary": "Investing.com -- RBC analysts say U.S. large cap pharma offers defensive exposure and earnings upside as artificial intelligence reshapes drug development.",
    "url": "https://finance.yahoo.com/news/large-cap-pharma-defensive-ai-145720870.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "38db119c-9f44-3acf-9b13-4ff354235b4a",
      "content": {
        "id": "38db119c-9f44-3acf-9b13-4ff354235b4a",
        "contentType": "STORY",
        "title": "Large cap pharma defensive AI winner, says RBC as it backs Lilly & AbbVie",
        "description": "",
        "summary": "Investing.com -- RBC analysts say U.S. large cap pharma offers defensive exposure and earnings upside as artificial intelligence reshapes drug development.",
        "pubDate": "2026-02-25T14:57:20Z",
        "displayTime": "2026-02-25T14:57:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/large-cap-pharma-defensive-ai-145720870.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/large-cap-pharma-defensive-ai-145720870.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-25T20:29:45+00:00",
    "headline": "Aldeyra Therapeutics CEO Highlights Reproxalap Ahead of March 16 FDA Decision at Oppenheimer Conference",
    "summary": "Aldeyra Therapeutics (NASDAQ:ALDX) CEO Todd Brady provided an update on the company’s late-stage ophthalmology programs and broader pipeline during a fireside chat at Oppenheimer’s 36th Annual Healthcare Life Sciences Conference, with much of the discussion centered on the pending FDA decision for r",
    "url": "https://www.marketbeat.com/instant-alerts/aldeyra-therapeutics-ceo-highlights-reproxalap-ahead-of-march-16-fda-decision-at-oppenheimer-conference-2026-02-25/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "70592dd5-cd74-346c-8601-f8423323326f",
      "content": {
        "id": "70592dd5-cd74-346c-8601-f8423323326f",
        "contentType": "STORY",
        "title": "Aldeyra Therapeutics CEO Highlights Reproxalap Ahead of March 16 FDA Decision at Oppenheimer Conference",
        "description": "",
        "summary": "Aldeyra Therapeutics (NASDAQ:ALDX) CEO Todd Brady provided an update on the company’s late-stage ophthalmology programs and broader pipeline during a fireside chat at Oppenheimer’s 36th Annual Healthcare Life Sciences Conference, with much of the discussion centered on the pending FDA decision for r",
        "pubDate": "2026-02-25T20:29:45Z",
        "displayTime": "2026-02-25T20:29:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/c5a4b799de0af8163ca2c76b6001fe90",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Aldeyra Therapeutics logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3jt4q.8SVmCBt7gqmKWrww--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/c5a4b799de0af8163ca2c76b6001fe90.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/731mUm1cgfGp3KUTU.Xo4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/c5a4b799de0af8163ca2c76b6001fe90.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/aldeyra-therapeutics-ceo-highlights-reproxalap-ahead-of-march-16-fda-decision-at-oppenheimer-conference-2026-02-25/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/aldeyra-therapeutics-ceo-highlights-reproxalap-202945010.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "ALDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]